Thank you for your reply. I think Biowatch may be on to something, though.
I believe he is drawing a distinction between a) using someone else's patented methods to discover something and b) the possible lack of usage of those patented methods in the manufacturing of a copy of the brand name drug.
Granted, one might also have to use the patented methods to do quality checks during production - which is then a violation.
Let's assume that TEVA used/is using MNTA patented methods to discover contents of something. The portion of text you quoted, by itself (and as I read it) does not preclude the manufacture of a product discovered by using someone else's patented methods, the portion of text only precludes the manufacture of something using someone else's patented methods during manufacturing.
So, if TEVA is making something w/o using someone else's patented methods in the manufacturing process, they might not be subject to liability/penalty for that portion of their operations.
I may be splitting hairs, but I can see some small wiggle room.
Of course, given the intellectual firepower on this board, I reserve the right to be considered totally clueless.
Market Data 
Markets 
AI
